Aflibercept 16-Week Dosing Regimen for Diabetic Retinopathy Under Review
The sBLA is supported by data from the phase 3 PANORAMA trial and the NIH-sponsored Protocol W trial.
Health news
The sBLA is supported by data from the phase 3 PANORAMA trial and the NIH-sponsored Protocol W trial.
Positive topline results were announced from a phase 3 study evaluating the twice daily administration of Vuity (pilocarpine HCl ophthalmic solution) 1.25% in adults with presbyopia. The multicenter, double-masked, randomized, vehicle-controlled parallel-group VIRGO study (ClinicalTrials.gov…
Xipere® (triamcinolone acetonide injectable suspension) is now available for suprachoroidal use for the treatment of macular edema associated with uveitis. The approval of Xipere was based on data from the phase 3 PEACHTREE trial (ClinicalTrials.gov…
Lastacaft® (alcaftadine ophthalmic solution 0.25%) is now available for sale over-the-counter (OTC). In December 2021, the Food and Drug Administration (FDA) approved the prescription to OTC switch for Lastacaft, an H1 histamine receptor antagonist. The…
The Food and Drug Administration (FDA) has approved Acuvue® Theravision with Ketotifen (etafilcon A drug-eluting contact lens with ketotifen) for the prevention of ocular itch due to allergic conjunctivitis and correction of refractive ametropia (myopia…
The Food and Drug Administration (FDA) has approved Mylan Pharmaceuticals’ cyclosporine ophthalmic emulsion 0.05% single-use vials (eye drops), the first generic version of Restasis. Cyclosporine ophthalmic emulsion is a calcineurin inhibitor immunosuppressant indicated to increase…
The Food and Drug Administration (FDA) has granted Orphan Drug designation to visomitin for the treatment of Leber hereditary optic neuropathy (LHON), a rare genetic disease characterized by the degeneration of retinal ganglion cells that…
Tyrvaya (varenicline solution) nasal spray is now available for the treatment of signs and symptoms of dry eye disease. Tyrvaya contains varenicline, a highly selective nicotinic acetylcholine agonist, which stimulates natural tear film production by…
The Food and Drug Administration (FDA) has approved Vuity (pilocarpine HCI ophthalmic solution) for the treatment of presbyopia in adults. Vuity is a cholinergic muscarinic receptor agonist designed to improve near and intermediate vision without…
The Food and Drug Administration (FDA) has approved Xipere (triamcinolone acetonide injectable suspension) for suprachoroidal use for the treatment of macular edema associated with uveitis. The approval was based on data from the multicenter, randomized,…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021